RSV Vaccine Effectiveness Against Hospitalization Among US Adults 60 Years and Older
Author:
Surie Diya1, Self Wesley H.2, Zhu Yuwei3, Yuengling Katharine A.1, Johnson Cassandra A.3, Grijalva Carlos G.4, Dawood Fatimah S.1, , Gaglani Manjusha5, Ghamande Shekhar5, McNeal Tresa5, Columbus Cristie5, Gottlieb Robert L.5, Steingrub Jay S.5, DeCuir Jennifer5, McMorrow Meredith L.5, Ellington Sascha5, Lewis Nathaniel M.5, Duggal Abhijit5, Busse Laurence W.5, Bender William S.5, Prekker Matthew E.5, Frosch Anne5, Peltan Ithan D.5, Brown Samuel M.5, Hager David N.5, Gong Michelle N.5, Mohamed Amira5, Khan Akram5, Hough Catherine L.5, Wilson Jennifer G.5, Mosier Jarrod M.5, Qadir Nida5, Chang Steven Y.5, Ginde Adit A.5, Mohr Nicholas M.5, Zepeski Anne5, Mallow Christopher5, Lauring Adam S.5, Martin Emily T.5, Leis Aleda M.5, Harris Estelle S.5, Johnson Nicholas J.5, Srinivasan Vasisht5, Talbot H. Keipp5, Halasa Natasha5, Chappell James D.5, Womack Kelsey N.5, Rhoads Jillian P.5, Baughman Adrienne5, Swan Sydney A.5, Rice Todd W.5, Casey Jonathan D.5, Blair Paul W.5, Gibbs Kevin W.5, Kwon Jennie H.5, Parikh Bijal5, Vaughn Ivana A.5, Ramesh Mayur5, Safdar Basmah5
Affiliation:
1. Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, Georgia 2. Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tennessee 3. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee 4. Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee 5. for the Investigating Respiratory Viruses in the Acutely Ill (IVY) Network
Abstract
This study evaluates the effectiveness of the respiratory syncytial virus vaccine against hospitalization for acute respiratory illness among US adults aged 60 years and older.
Publisher
American Medical Association (AMA)
|
|